TRCT
OSCR icon

Tower Research Capital (TRC)’s Oscar Health OSCR Stock Holding History

Tower Research Capital (TRC)’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Sell
7,681
-10,963
-59% -$236K 0.01% 1625
2026
Q1 		$214K Buy
18,644
+13,798
+285% +$194K 0.01% 1567
2025
Q4 		$69.6K Buy
4,846
+1,375
+40% +$23.8K ﹤0.01% 2196
2025
Q3 		$65.7K Sell
3,471
-27,028
-89% -$445K ﹤0.01% 2312
2025
Q2 		$654K Buy
30,499
+22,349
+274% +$332K 0.02% 775
2025
Q1 		$107K Buy
8,150
+1,523
+23% +$22.6K ﹤0.01% 1740
2024
Q4 		$89.1K Buy
6,627
+4,185
+171% +$67.4K ﹤0.01% 2206
2024
Q3 		$51.8K Sell
2,442
-43,018
-95% -$775K ﹤0.01% 2701
2024
Q2 		$719K Buy
45,460
+39,975
+729% +$735K 0.01% 1020
2024
Q1 		$81.6K Sell
5,485
-32,909
-86% -$451K ﹤0.01% 1947
2023
Q4 		$351K Buy
38,394
+33,867
+748% +$234K ﹤0.01% 1661
2023
Q3 		$25.2K Sell
4,527
-4,188
-48% -$29.3K ﹤0.01% 3163
2023
Q2 		$70.2K Sell
8,715
-15,395
-64% -$114K ﹤0.01% 2304
2023
Q1 		$158K Buy
24,110
+23,308
+2,906% +$95.2K 0.01% 1505
2022
Q4 		$2K Sell
802
-16,154
-95% -$50.5K ﹤0.01% 5403
2022
Q3 		$85K Buy
16,956
+6,605
+64% +$38.6K ﹤0.01% 2703
2022
Q2 		$44K Buy
10,351
+3,463
+50% +$22K ﹤0.01% 3020
2022
Q1 		$69K Buy
+6,888
New +$51.2K ﹤0.01% 2483
2021
Q4 		– Sell
-492
Closed -$9K – 6443
2021
Q3 		$9K Sell
492
-9,432
-95% -$160K ﹤0.01% 4460
2021
Q2 		$214K Buy
+9,924
New +$238K 0.01% 1875

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s OSCR Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Oscar Health (OSCR) stake by 59% in Q2 2026, selling an estimated $236K and leaving 7,681 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #1625.

Tower Research Capital (TRC) first reported a position in OSCR in Q2 2021 and has held it in 20 quarters since. The position peaked at $719K in Q2 2024. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Tower Research Capital (TRC) held 7,681 shares of Oscar Health worth $219K as of Q2 2026.
  • Tower Research Capital (TRC) sold 10,963 Oscar Health shares in Q2 2026, an estimated $236K.
  • Oscar Health made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1625 holding.
  • Tower Research Capital (TRC) first reported a position in Oscar Health in Q2 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Oscar Health position peaked at $719K in Q2 2024.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.